Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Find out more

Passionate about Science

World-class drug discovery expertise
and an unprecedented track record with 4 drugs on the market

Find out more

Integrated
Drug Discovery

Target
Validation

Hit
Identification

Hit
to Lead

Lead
Optimization

Want to get an insight into IRBM and why we are so passionate about science? Watch our new video

IRBM Brochure
Corporate Brochure

We have been instrumental in the discovery of four drugs now on the market

We leverage our accomplishments in drug discovery with our determination to remain at the cutting edge of research to deliver innovation for industry and academia. As your partner, we provide you with robust and cutting edge scientific expertise, honed in global pharma, along with the steadfast support required in a fast-paced and challenging industry.

IRBM Passion

PASSION

Science is our cornerstone. Our unprecedented track record in discovering drugs demonstrates this. We capitalize on our shared enthusiasm for innovative R&D, spurred on by our dedication to deliver excellence at every opportunity.

IRBM Expertise

EXPERTISE

Our expertise spans different modalities including small molecule, peptide and biologic therapeutics. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

IRBM Collaboration

COLLABORATION

Our partners are of the utmost importance. We always strive to go above and beyond your expectations, treating your projects as our highest priority.

WHYUS

We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.

Publications

Read more

Track Record

Read more

LatestNews

Discovery Bites From IRBM

Discovery Bites from IRBM

31 August 2023
Events
Discovery Bites from IRBM
Read more →

IRBM EFMC – ASMC 2023

31 August 2023
Events
Be sure to visit posters P225 and P277 at the IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC 2023) in Zagreb, Croatia from 3 – 7 September to learn more about IRBM's exciting #research on novel allosteric SHP2 inhibitors!

IRBM, Rainwater Charitable Foundation and Weill Cornell Medicine Join Forces to Progress Therapies for Neurodegenerative Disorders

12 July 2023
IRBM in the News, Press Releases
IRBM, Rainwater Charitable Foundation (RCF, based in Fort Worth, Texas), a private family foundation, and Weill Cornell Medicine (based in New York) announce the start of a multi-year drug discovery collaboration to identify small molecule cGAS (cyclic GMP-AMP synthase) inhibitors for the treatment of tauopathies and other neurodegenerative diseases. Financial details are not disclosed.

IRBM Extends Peptide Therapeutics Collaboration with Merck & Co. Inc. Rahway NJ USA

23 June 2023
IRBM in the News, Press Releases
IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD outside the USA and Canada, to continue their collaboration in the peptide therapeutics area.
The Power of NMR in Drug Discovery

The Power of NMR in Drug Discovery

Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.

read more
Back To Top